MYDA Advisors’s Allergan plc AGN Stock Holding History

MYDA Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$1.34M	–	148
2018 Q4	$1.34M	Buy	10,000 +3,000	+43%	+$492K	2.3%	14
2018 Q3	$1.33M	Buy	+7,000	New	+$1.29M	0.72%	33

Other funds holding AGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MYDA Advisors's AGN Position: Q1 2019 in Review

MYDA Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 10,000 shares — an estimated $1.34M sold.

MYDA Advisors first reported a position in AGN in Q3 2018 and held it in 2 quarters. The position peaked at $1.34M in Q4 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

MYDA Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
MYDA Advisors sold 10,000 Allergan plc shares in Q1 2019, an estimated $1.34M.
MYDA Advisors first reported a position in Allergan plc in Q3 2018 and held it in 2 quarters.
MYDA Advisors's Allergan plc position peaked at $1.34M in Q4 2018.
991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on MYDA Advisors's 13F filing for Q1 2019, filed 13 May 2019.